ACTIVATION OF TUMOR-SPECIFIC CTLP TO A CYTOLYTIC STAGE REQUIRES ADDITIONAL SIGNALS

被引：0
|
作者：
VONHOEGEN, P
SCHIRRMACHER, V
机构：
来源：
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 1988年 / 532卷
关键词：
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：468 / 471
页数：4
相关论文
共 50 条
  • [1] PREVENTION OF METASTATIC SPREAD BY POSTOPERATIVE IMMUNOTHERAPY WITH VIRALLY MODIFIED AUTOLOGOUS TUMOR-CELLS .3. POSTOPERATIVE ACTIVATION OF TUMOR-SPECIFIC CTLP FROM MICE WITH METASTASES REQUIRES STIMULATION WITH THE SPECIFIC ANTIGEN PLUS ADDITIONAL SIGNALS
    VONHOEGEN, P
    HEICAPPELL, R
    GRIESBACH, A
    ALTEVOGT, P
    SCHIRRMACHER, V
    INVASION & METASTASIS, 1989, 9 (02): : 117 - 133
  • [2] EXPANSION OF TUMOR-SPECIFIC CYTOLYTIC LYMPHOCYTES-T USING INVITRO RESTIMULATION WITH TUMOR-SPECIFIC TRANSPLANTATION ANTIGEN
    NAITO, K
    PELLIS, NR
    KAHAN, BD
    CELLULAR IMMUNOLOGY, 1987, 108 (02) : 483 - 494
  • [3] PRODUCTION OF TUMOR-SPECIFIC ANTIGENS BY ONCOGENIC VIRUSES DURING ACUTE CYTOLYTIC INFECTIONS
    HOGGAN, MD
    ROWE, WP
    BLACK, PH
    HUEBNER, RJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1965, 53 (01) : 12 - &
  • [4] CYTOLYTIC MICROASSAYS AND STUDIES OF SV40 TUMOR-SPECIFIC TRANSPLANTATION ANTIGEN
    SMITH, RW
    MORA, PT
    VIROLOGY, 1972, 50 (01) : 233 - &
  • [5] Masked Chimeric Antigen Receptor for Tumor-Specific Activation
    Han, Xiaolu
    Bryson, Paul D.
    Zhao, Yifan
    Cinay, Gunce E.
    Li, Si
    Guo, Yunfei
    Siriwon, Natnaree
    Wang, Pin
    MOLECULAR THERAPY, 2017, 25 (01) : 274 - 284
  • [6] Tumor-specific activation of prodrugs: is there a role for nuclear medicine?
    Antunes, Ines F.
    Haisma, Hidde J.
    de Vries, Erik F. J.
    NUCLEAR MEDICINE COMMUNICATIONS, 2008, 29 (10) : 845 - 846
  • [7] PRODRUGS OF ANTHRACYCLINE ANTIBIOTICS SUITED FOR TUMOR-SPECIFIC ACTIVATION
    AZOULAY, M
    FLORENT, JC
    MONNERET, C
    GESSON, JP
    JACQUESY, JC
    TILLEQUIN, F
    KOCH, M
    BOSSLET, K
    CZECH, J
    HOFFMAN, D
    ANTI-CANCER DRUG DESIGN, 1995, 10 (06): : 441 - 450
  • [8] Tumor-specific fluorescence activation of rhodamine isothiocyanate derivatives
    Hu, Shiqi
    Jiang, Haiping
    Zhu, Jianqiang
    Wang, Jinqiang
    Wang, Shunhao
    Tang, Jianbin
    Zhou, Zhuxian
    Liu, Sijin
    Shen, Youqing
    Journal of Controlled Release, 2021, 330 : 842 - 850
  • [9] Tumor-specific fluorescence activation of rhodamine isothiocyanate derivatives
    Hu, Shiqi
    Jiang, Haiping
    Zhu, Jianqiang
    Wang, Jinqiang
    Wang, Shunhao
    Tang, Jianbin
    Zhou, Zhuxian
    Liu, Sijin
    Shen, Youqing
    JOURNAL OF CONTROLLED RELEASE, 2021, 330 : 842 - 850
  • [10] Robust tumor-specific cytolytic activity induced by B7-DC crosslinking
    Heckman, K
    Radhakrishnan, S
    Hansen, MJ
    Pease, LR
    FASEB JOURNAL, 2005, 19 (04): : A362 - A362
12345